HOME > > Products > Glac Single Strain Probiotic > L. reuteri GL-104
L. reuteri GL-104
A patented functional strain derived from the healthy human gut
GL-104 is a probiotic strain isolated from the healthy human intestinal tract. With a robust patent portfolio and multiple peer-reviewed studies, GL-104 has demonstrated strong potential in allergy modulation, oral health, and blood glucose regulation. It has been successfully incorporated into several PRONULIFE® clinically validated formulations.
Core Areas of Application
Allergy Support: Research indicates its potential to modulate immune responses and help reduce allergic symptoms.
Oral Health: Patents demonstrate its ability to inhibit oral pathogens, supporting applications in food and oral care products.
- Blood Glucose Regulation: Patents and clinical data highlight its potential role in maintaining healthy blood glucose balance.
Functional Applications in PRONULIFE® Formulations
 | |
| Immune & Allergy Support PRONULIFE® NosRelieve / BabyAllieve |
Key Patents
Taiwan
I639389: Food and pharmaceutical compositions of lactic acid bacteria for inhibiting oral pathogens
I709374: Food and pharmaceutical compositions of lactic acid bacteria for lowering blood glucose
I777107: Food and pharmaceutical compositions containing antioxidant lactic acid bacteria fermentation products
China
CN102309001B: Food and pharmaceutical compositions of lactic acid bacteria for supporting allergy modulation
CN108338361B: Food, oral hygiene, and pharmaceutical compositions containing lactic acid bacteria for oral health
United States
- US11612171B2: Food and pharmaceutical compositions with lactic acid bacteria strains and method for modulating blood glucose
📧 Contact us: glac@glac.com.tw
Further Reading:
- Glac Single Strain Probiotic Powder - Live Probiotic Powder
- PRONULIFE® Functional Probiotic Ingredients
References
- Effects of a Probiotic Formulation on Seasonal Allergic Rhinitis in Adults—A Randomized Double-Blind Placebo-Controlled Trial The Probiotics for Hay Fever Trial
